Raymond Anderson
Director at Monopar Therapeutics (MNPR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $703K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 6947,821 held (−8%) | $110.04 | $76K | -28.2% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 6467,175 held (−8%) | $111.07 | $72K | -28.9% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 1,8025,373 held (−25%) | $113.05 | $204K | -30.2% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 69426,169 held (−3%) | $110.04 | $76K | -28.2% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 64625,523 held (−2%) | $110.07 | $71K | -28.3% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 1,80223,751 held (−7%) | $113.05 | $204K | -30.2% |
- Sell
Director Raymond Anderson sold $76K of MNPR at $110.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Raymond Anderson sold $72K of MNPR at $111.07 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Raymond Anderson sold $204K of MNPR at $113.05 — cuts the stake by 25%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Raymond Anderson sold $76K of MNPR at $110.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Raymond Anderson sold $71K of MNPR at $110.07 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Raymond Anderson sold $204K of MNPR at $113.05 — pre-scheduled 10b5-1 plan sale.